TGFBR3, a potential negative regulator of TGF-β signaling, protects cardiac fibroblasts from hypoxia-induced apoptosis

Journal of Cellular Physiology

Volumn 226, Issue 10, 2011, Pages 2586-2594

  Chu, Wenfeng ^a   Li, Xiaoxue ^a   Li, Cui ^a   Wan, Lin ^a   Shi, Hui ^a   Song, Xiaohui ^a   Liu, Xingyuan ^a   Chen, Xi ^a   Zhang, Chun ^a   Shan, Hongli ^a   Lu, Yanjie ^a   Yang, Baofeng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PROTEIN BAX; PROTEIN BCL 2; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS REGULATORY PROTEINS; CELL HYPOXIA; CELLS, CULTURED; DOWN-REGULATION; FIBROBLASTS; MICE; MICE, INBRED STRAINS; MYOCYTES, CARDIAC; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 79960670510     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22604     Document Type: Article

References (45)

1. Ahn JY, Park S, Yun YS, Song JY. 2010. Inhibition of type III TGF-beta receptor aggravates lung fibrotic process. Biomed Pharmacother 64: 472-476.
2. Andjelic S, Khanna A, Suthanthiran M, Nikolic-Zugic J. 1997. Intracellular Ca2+ elevation and cyclosporin A synergistically induce TGF-beta 1-mediated apoptosis in lymphocytes. J Immunol 158: 2527-2534.
3. Attisano L, Wrana JL. 1996. Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev 7: 327-339.
4. Baudino TA, Carver W, Giles W, Borg TK. 2006. Cardiac fibroblasts: Friend or foe? Am J Physiol Heart Circ Physiol 291: H1015-H1026.
5. Blobe GC, Schiemann WP, Pepin MC, Beauchemin M, Moustakas A, Lodish HF, O'Connor-McCourt MD. 2001. Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. J Biol Chem 276: 24627-24637.
6. Brown RD, Ambler SK, Mitchell MD, Long CS. 2005. The cardiac fibroblast: Therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45: 657-687.
7. Burstein B, Nattel S. 2008. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51: 802-809.
8. Callis TE, Cao D, Wang DZ. 2005. Bone morphogenetic protein signaling modulates myocardin transactivation of cardiac genes. Circ Res 97: 992-1000.
9. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. 2000. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis. J Mol Cell Cardiol 32: 1805-1819.
10. Chu WF, Sun HL, Dong DL, Qiao GF, Yang BF. 2006. Increasing Intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through IP3 pathway. Basic Clin Pharmacol Toxicol 98: 104-109.
11. Deng L, Huang B, Qin D, Ganguly K, El-Sherif N. 2001. Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling. J Cardiovasc Electrophysiol 12: 1055-1061.
12. Deveraux QL, Schendel SL, Reed JC. 2001. Antiapoptotic proteins. The bcl-2 and inhibitor of apoptosis protein families. Cardiol Clin 19: 57-74.
13. Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG. 2002. Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function. J Biol Chem 277: 823-829.
14. Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, Ochoa MS. 1993. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol 157: 408-412.
15. Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501.
16. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z. 1993a. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7: 659-670.
17. Gorczyca W, Gong J, Darzynkiewicz Z. 1993b. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53: 1945-1951.
18. Han H, Wang H, Long H, Nattel S, Wang Z. 2001. Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem 276: 26357-26364.
19. Han H, Long H, Wang H, Wang J, Zhang Y, Wang Z. 2004. Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: A novel pattern of apoptosis and the mechanisms. Am J Physiol Heart Circ Physiol 286: H2169-H2182.
20. Hermida N, Lopez B, Gonzalez A, Dotor J, Lasarte JJ, Sarobe P, Borras-Cuesta F, Diez J. 2009. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats. Cardiovasc Res 81: 601-609.
21. Hong KH, Yoo SA, Kang SS, Choi JJ, Kim WU, Cho CS. 2006. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol 146: 362-370.
22. Jensen LT, Host NB. 1997. Collagen: Scaffold for repair or execution. Cardiovasc Res 33: 535-539.
23. Kim HS, Chang WC, Hwang KC, Choi IG, Park WK. 2008. Effect of propofol on calcium homeostasis in hypoxia-reoxygenated neonatal rat cardiomyocytes. Eur J Pharmacol 594: 139-145.
24. Kim HS, Hwang KC, Park WK. 2010. Cardioprotection via modulation of calcium homeostasis by thiopental in hypoxia-reoxygenated neonatal rat cardiomyocytes. Yonsei Med J 51: 187-196.
25. LaFramboise WA, Scalise D, Stoodley P, Graner SR, Guthrie RD, Magovern JA, Becich MJ. 2007. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am J Physiol Cell Physiol 292: C1799-C1808.
26. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J. 1991. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67: 785-795.
27. Mayorga M, Bahi N, Ballester M, Comella JX, Sanchis D. 2004. Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death. J Biol Chem 279: 34882-34889.
28. Mockridge JW, Benton EC, Andreeva LV, Latchman DS, Marber MS, Heads RJ. 2000. IGF-1 regulates cardiac fibroblast apoptosis induced by osmotic stress. Biochem Biophys Res Commun 273: 322-327.
29. Nesti LJ, Caterson EJ, Wang M, Chang R, Chapovsky F, Hoek JB, Tuan RS. 2002. TGF-beta1-stimulated osteoblasts require intracellular calcium signaling for enhanced alpha5 integrin expression. Ann NY Acad Sci 961: 178-182.
30. Nesti LJ, Caterson EJ, Li WJ, Chang R, McCann TD, Hoek JB, Tuan RS. 2007. TGF-beta1 calcium signaling in osteoblasts. J Cell Biochem 101: 348-359.
31. Nishikawa S, Tatsumi T, Shiraishi J, Matsunaga S, Takeda M, Mano A, Kobara M, Keira N, Okigaki M, Takahashi T, Matsubara H. 2006. Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis. J Mol Cell Cardiol 40: 510-519.
32. Norman JT, Clark IM, Garcia PL. 2000. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58: 2351-2366.
33. Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O, Tavi P. 2007. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 21: 1821-1830.
34. Rook MB, van Ginneken AC, de Jonge B, el Aoumari A, Gros D, Jongsma HJ. 1992. Differences in gap junction channels between cardiac myocytes, fibroblasts, and heterologous pairs. Am J Physiol 263: C959-C977.
35. Saed GM, Diamond MP. 2002. Apoptosis and proliferation of human peritoneal fibroblasts in response to hypoxia. Fertil Steril 78: 137-143.
36. Schuster N, Krieglstein K. 2002. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 307: 1-14.
37. Shan H, Zhang Y, Lu Y, Pan Z, Cai B, Wang N, Li X, Feng T, Hong Y, Yang B. 2009. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 83: 465-472.
38. Steinbrech DS, Longaker MT, Mehrara BJ, Saadeh PB, Chin GS, Gerrets RP, Chau DC, Rowe NM, Gittes GK. 1999. Fibroblast response to hypoxia: The relationship between angiogenesis and matrix regulation. J Surg Res 84: 127-133.
39. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R. 2010. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 120: 254-265.
40. Tamamori M, Ito H, Hiroe M, Marumo F, Hata RI. 1997. Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides. Cell Biol Int 21: 175-180.
41. Vilchis-Landeros MM, Montiel JL, Mendoza V, Mendoza-Hernandez G, Lopez-Casillas F. 2001. Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent. Biochem J 355: 215-222.
42. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. 1991. Expression cloning and characterization of the TGF-beta type III receptor. Cell 67: 797-805.
43. Xie Y, Garfinkel A, Weiss JN, Qu Z. 2009. Cardiac alternans induced by fibroblast-myocyte coupling: Mechanistic insights from computational models. Am J Physiol Heart Circ Physiol 297: H775-H784.
44. Yang KL, Chang WT, Hung KC, Li EI, Chuang CC. 2008. Inhibition of transforming growth factor-beta-induced liver fibrosis by a retinoic acid derivative via the suppression of Col 1A2 promoter activity. Biochem Biophys Res Commun 373: 219-223.
45. Zhao D, Chu WF, Wu L, Li J, Liu QM, Lu YJ, Qiao GF, Wang ZG, Zhang ZR, Yang BF. 2010. PAF exerts a direct apoptotic effect on the rat H9c2 cardiomyocytes in Ca2+-dependent manner. Int J Cardiol 143: 86-93.